Completed Infection & Immunity Genetics & Molecular Biology

What is special about pandemic HIV-1? How capsid cofactor interactions regulate DNA synthesis, innate immune detection and pandemic potential

In plain English

AI plain-English summary

The HIV-1 pandemic arose from a single virus that jumped from chimpanzees to humans, but most related monkey viruses cannot spread between people. This project asks what makes that one virus so different. The answer appears to lie in the virus’s capsid—the protein shell that surrounds its genetic material. The capsid is not just a protective container; it acts as a molecular machine that recruits host cell proteins to orchestrate infection while dodging the immune system. The researchers will use structural biology, single-molecule techniques, and chemical biology to map exactly how the capsid interacts with host cofactors, how those interactions control DNA synthesis and genome uncoating, and how they allow the virus to evade innate immune detection. This is fundamental science. It addresses a long-standing gap in understanding why only certain lentiviruses become pandemics. If successful, the work could reveal why HIV-1 is uniquely transmissible among humans and identify new vulnerabilities in the capsid. The team also has a series of novel capsid inhibitors that they will use as research tools—and potentially as the basis for a new class of antiviral drugs. Deeper knowledge of capsid mechanics could eventually inform pandemic preparedness and treatment strategies, though practical applications remain downstream.

View original technical description
The HIV-1 pandemic originates from one of many zoonotic simian lentiviruses. A key unanswered question is: what is special about pandemic HIV-1? Our previous work suggests a pivotal role for lentiviral capsids as molecular machines that determine innate immune evasion capacity and pandemic potential. Lentiviral capsids simultaneously regulate viral DNA synthesis, viral genome uncoating, nuclear entry and integration targeting, through coordinated and dynamic recruitment of host cofactors. The goal of this application is to understand how capsids work by considering the structural changes that result from interactions with known and novel cellular cofactors and drugs, the biological consequences of these changes and how they drive infection, zoonosis and pandemicity. We propose three aims that integrate structural, single-molecule and chemical biology with comparative virology. In aim one we will use state of the art structural approaches to understand cofactor capsid interactions. In aim two we will determine how host cofactors manipulate capsid function to temporally and spatially orchestrate DNA synthesis and genome uncoating to facilitate evasion of innate immunity. In aim three we will use our novel CA inhibitor series as tools to probe capsid function and to develop a new paradigm for treatment of infection.

View the original record at the funder ↗

Researchers

David Jacques (EPMC Awardee)David Selwood (EPMC Awardee)Greg Towers (EPMC Awardee)Leo James (EPMC Awardee)Till Boecking (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Resolving HIV-1 transport and host cofactor regulation in the cellular context
Assembly Cofactors of HIV-1
Investigating the structural basis for HIV-1 hijacking cytoskeletal motor adaptors and in situ studies of microtubule trafficking
Characterisation of host virus interactions.
Primate lentiviral Vpx: insights into DNA sensing and zoonotic potential

Original classification

Collaborative Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.